Europe Negative Pressure Wound Therapy Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

Europe Negative Pressure Wound Therapy Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

Europe's Negative Pressure Wound Therapy Market is expected to register a CAGR of 5.6% over the forecast period.

The COVID-19 pandemic caused collateral damage in health care in terms of reduced hospital submissions or postponed treatment of other acute or chronic ill patients. For instance, the article titled "Impact of COVID-19 on wound care in Germany" published in the International Wound Journal in February 2021 included sixty-three patients diagnosed with any kind of ulceration or chronic wound in the survey. Out of these, 14% of patients' diagnostic workup or hospitalization was canceled or delayed. 36% could not visit their primary care physician as usual for advice. The survey indicated that Germany's COVID-19 pandemic impaired access to clinical management of chronic wounds. Thus COVID-19 adversely impacted the studied market.

The surgeries and elective procedures postponed due to COVID-19 began to resume as the cases declined worldwide which has led to a boost in the market growth as there are chances of getting a wound after a surgery. For instance, according to an article published in June 2021, titled "German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery," there were approximately 29,444 isolated coronary artery bypass grafting procedures, 35,469 isolated heart valve procedures, and 843 assist device implantations registered in Germany. According to the same source, the number of solitary heart transplants in Germany has surged to 340, a 2.1% increase over the previous year. Hence, an increasing number of surgeries are anticipated to play a significant role in the European negative pressure wound therapy market over the forecast period.

In addition, the increasing number of accidents and traumatic events, rising chronic wounds such as diabetic foot ulcers, and technological advancements in NPWT devices are actively affecting the growth of the studied market.

An article titled "Cumulative long-term recurrence of diabetic foot ulcers in two cohorts from centres in Germany and the Czech Republic" published in Diabetes Research and Clinical Practice Journal in February 2021 stated that 69% (154) of patients in Germany and 70% (69) in Czech Republic experienced at least one diabetic foot ulcers (DFU) recurrence. The study stated that cumulative DFU recurrence was approximately 70% in 15 years in both groups. The high incidence of diabetic foot ulcers and its recurrence is expected to boost the demand for negative pressure wound therapy market.

According to the European Pressure Ulcer Advisory Panel 2022 report, Pressure Ulcer Day is hosted in November every year in Europe to spread awareness about the disease. The upcoming event is likely to be hosted in November 2022 with an aim to stop pressure ulcer. Such events are likely to spread awareness regarding the negative pressure wound therapy in the management of pressure ulcer which is projected to boost the growth of the studied market.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. however, the high cost of devices and treatment and complications associated With NPWT devices are likely to impede the market growth.

Key Market TrendsDiabetic Foot Ulcers are Expected to Witness Growth Over The Forecast Period.

Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and are posing a significant burden on several countries across the European region.

Diabetic foot ulcer occurs in approximately 15% of patients with diabetes and therefore the increasing diabetic population in the region is contributing to the dominant share of the segment. For instance, according to the International Diabetes Federation Diabetes Atlas, February 2022 report, an estimated 61 million adults (20-79 years) were living with diabetes in the Europe Region in 2021. The number of adults with diabetes is predicted to rise to 69 million by 2045, an increase of 13%. The surge in the prevalence of diabetes among all ages in the European Region is likely to increase the cases of diabetic foot ulcers in the region which is ultimately projected to augment the segment's growth.

The launches and acquisitions by the market players are likely to augment the market growth. For instance, in April 2021, Noventure, a Spain-based company acquired the Ulkox and Oleoabrax products, based on an Olea Europaea leaf extract wound-healing technology. Such developments are expected to boost the segment growth in the region.

Germany is is Expected to Dominate the Europe Negative Pressure Wound Therapy Market.

Germany is expected to dominate the market owing to factors such as the rising incidence of diabetic foot ulcer cases, the strong presence of industry players in the region, better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the country.

The approvals, launches, acquisitions, and partnerships by the key market players in the country are projected to boost the market growth. In June 2021, Bactiguard and German company Schülke & Mayr GmbH signed a distribution agreement for Bactiguard’s range of wound care solutions to German hospitals. The collaboration is predicted to augment the demand for wound management in the country and ultimately boost the market growth.

The Federal Statistical Office (Destatis) August 2022 report stated that approximately 22,300 children aged under 15 years were harmed in road traffic accidents in 2021 in Germany. The accidents are associated with developing a wound that requires negative pressure wound therapy for its management which is ultimately boosting the market growth.

Therefore, owing to the aforementioned factors, the studied market's growth is anticipated in Germany.

Competitive Landscape

The Europe Negative Pressure Wound Therapy Market is slightly consolidated in nature due to the presence of a few companies operating regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. Some major players are Molnlycke Health Care AB, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M, Talley Group Limited, Devon Medical, Inc, Medela AG, and DeRoyal Industries, Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.